{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:19:48Z","timestamp":1792790388882,"version":"4.5.0"},"reference-count":31,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:p>Background: Probiotics use has been associated with modulation of inflammation and considered as a possible intervention for CNS diseases such as mild cognitive impairment (MCI) and dementia. Objective: We aimed to test the effect of the probiotic strain, Bifidobacterium breve A1 (MCC1274), to restore cognition in a physically healthy, suspected MCI population. Methods: In this randomized, double-blind, placebo-controlled trial, 80 healthy older adults suffering from MCI were divided into two even groups to receive once daily either probiotic (B. breve A1, 2\u00d71010 CFU) or placebo for 16 weeks using a computer-generated algorithm. Cognitive functions were assessed by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Japanese version of the MCI Screen (JMCIS) tests before and after the study as primary and secondary endpoints, respectively. Results: 79 participants completed the study, and no adverse events were observed. RBANS total score was significantly improved in probiotic group compared with placebo (mean between-group difference 11.3 [95% CI 6.7 to 15.8]; p\u200a&lt;\u200a0.0001) after 16 weeks of consumption, in particular with significant improvement in domain scores of immediate memory, visuospatial\/constructional, and delayed memory (p\u200a&lt;\u200a0.0001), in both intention-to-treat (ITT) analysis and per-protocol (PP) analysis. JMCIS score was also improved versus placebo in ITT analysis (p\u200a=\u200a0.052) and PP analysis (p\u200a=\u200a0.036). Conclusion: Study results indicate B. breve A1 is a safe and effective approach for improving memory functions of suspected MCI subjects.<\/jats:p>","DOI":"10.3233\/jad-200488","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T13:54:12Z","timestamp":1593784452000},"page":"139-147","source":"Crossref","is-referenced-by-count":190,"title":["Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial"],"prefix":"10.1177","volume":"77","author":[{"given":"Jinzhong","family":"Xiao","sequence":"first","affiliation":[{"name":"Morinaga Milk Industry Co., Ltd., Next Generation Science Institute, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Katsumata","sequence":"additional","affiliation":[{"name":"Morinaga Milk Industry Co., Ltd., Next Generation Science Institute, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Bernier","sequence":"additional","affiliation":[{"name":"Morinaga Milk Industry Co., Ltd., Next Generation Science Institute, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Ohno","sequence":"additional","affiliation":[{"name":"Morinaga Milk Industry Co., Ltd., Next Generation Science Institute, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Morinaga Milk Industry Co., Ltd., Next Generation Science Institute, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Odamaki","sequence":"additional","affiliation":[{"name":"Morinaga Milk Industry Co., Ltd., Next Generation Science Institute, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Huma R & D Co. Ltd, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumie","family":"Ito","sequence":"additional","affiliation":[{"name":"Nihonbashi Sakura Clinic, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Tokyo Skytree Station Medical Clinic, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-200488_ref1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.58.3.397","article-title":"Mild cognitive impairment represents early-stage Alzheimer disease","volume":"58","author":"Morris","year":"2001","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-200488_ref2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/joim.12190","article-title":"Mild cognitive impairment: A concept in evolution","volume":"275","author":"Petersen","year":"2014","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-200488_ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0609-7","article-title":"Clinical trials of new drugs for Alzheimer disease","volume":"27","author":"Huang","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.3233\/JAD-200488_ref4","first-page":"150","article-title":"Editorial: Failure after failure. What next in AD drug development?","volume":"6","author":"Aisen","year":"2019","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-200488_ref5","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1038\/s41598-017-05903-y","article-title":"polymicrobial infections in brain tissue from Alzheimer\u2019s disease patients","volume":"7","author":"Pisa","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-200488_ref6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fgene.2018.00362","article-title":"Role of microbes in the development of Alzheimer\u2019s disease: State of the Art - An International Symposium Presented at the 2017 IAGG Congress in San Francisco","volume":"9","author":"F\u00fcl\u00f6p","year":"2018","journal-title":"Front Genet"},{"key":"10.3233\/JAD-200488_ref7","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.euroneuro.2019.10.011","article-title":"Nutritional psychiatry: Towards improving mental health by what you eat","volume":"29","author":"Adan","year":"2019","journal-title":"Neuropsychopharmacol"},{"key":"10.3233\/JAD-200488_ref8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1186\/s12889-019-7027-3","article-title":"Physical exercise for prevention of dementia (EPD) study: Background, design and methods","volume":"19","author":"Iuliano","year":"2019","journal-title":"BMC Public Health"},{"key":"10.3233\/JAD-200488_ref9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res"},{"key":"10.3233\/JAD-200488_ref10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jalz.2018.12.017","article-title":"A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment","volume":"15","author":"Fortier","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-200488_ref12","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol Rev"},{"key":"10.3233\/JAD-200488_ref13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1172\/JCI58648","article-title":"The adaptive immune system in diseases of the central nervous system Find the latest version: Review series The adaptive immune system in diseases of the central nervous system","volume":"122","author":"Wraith","year":"2012","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-200488_ref14","doi-asserted-by":"crossref","first-page":"13510","DOI":"10.1038\/s41598-017-13368-2","article-title":"Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer\u2019s disease","volume":"7","author":"Kobayashi","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-200488_ref15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3920\/BM2018.0170","article-title":"Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: A randomised, double-blind, placebo-controlled trial","volume":"10","author":"Kobayashi","year":"2019","journal-title":"Benef Microbes"},{"key":"10.3233\/JAD-200488_ref16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1533317507312624","article-title":"Current topics in management: The Japanese MCI Screen for early detection of Alzheimer\u2019s disease and related disorders","volume":"23","author":"Cho","year":"2008","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-200488_ref17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/arclin\/act057","article-title":"The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer\u2019s disease","volume":"28","author":"Karantzoulis","year":"2013","journal-title":"Arch Clin Neuropsychol"},{"key":"10.3233\/JAD-200488_ref18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neures.2006.06.010","article-title":"Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction","volume":"56","author":"Kotani","year":"2006","journal-title":"Neurosci Res"},{"key":"10.3233\/JAD-200488_ref19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/09637486.2017.1365824","article-title":"Lactobacillus helveticus-fermented milk containing lactononadecapeptide (NIPPLTQTPVVVPPFLQPE) improves cognitive function in healthy middle-aged adults: A randomised, double-blind, placebo-controlled trial","volume":"69","author":"Ohsawa","year":"2018","journal-title":"Int J Food Sci Nutr"},{"key":"10.3233\/JAD-200488_ref20","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/hbm.20934","article-title":"Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer\u2019s disease","volume":"31","author":"Suzanne","year":"2010","journal-title":"Hum Brain Mapp"},{"key":"10.3233\/JAD-200488_ref21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/arclin\/acu012","article-title":"RBANS memory indices are related to medial temporal lobe volumetrics in healthy older adults and those with mild cognitive impairment","volume":"29","author":"England","year":"2014","journal-title":"Arch Clin Neuropsychol"},{"key":"10.3233\/JAD-200488_ref22","doi-asserted-by":"crossref","first-page":"11814","DOI":"10.1038\/s41598-019-48342-7","article-title":"Suppression of gut dysbiosis by Bifidobacterium longum alleviates cognitive decline in 5XFAD transgenic and aged mice","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-200488_ref23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pnpbp.2017.05.007","article-title":"Molecular imaging of neuroinflammation in Alzheimer\u2019s disease and mild cognitive impairment","volume":"80 (Pt B)","author":"Knezevic","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.3233\/JAD-200488_ref24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fmicb.2017.02345","article-title":"Bifidobacteria and their molecular communication with the immune system","volume":"8","author":"Ruiz","year":"2017","journal-title":"Front Microbiol"},{"key":"10.3233\/JAD-200488_ref25","first-page":"33","article-title":"The use of probiotic therapy to modulate the gut microbiota and dendritic cell responses in inflammatory bowel diseases","volume":"7","author":"Alag\u00f3n Fern\u00e1ndez del Campo","year":"2019","journal-title":"Med Sci (Basel)"},{"key":"10.3233\/JAD-200488_ref26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/microorganisms7090340","article-title":"Production of indole-3-lactic acid by Bifidobacterium strains isolated from human infants","volume":"7","author":"Sakurai","year":"2019","journal-title":"Microorganisms"},{"key":"10.3233\/JAD-200488_ref27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/microorganisms8030398","article-title":"Potential effects of indole-3-lactic acid, a metabolite of human bifidobacteria, on NGF- induced neurite outgrowth in PC12 cells","volume":"8","author":"Wang","year":"2020","journal-title":"Microorganisms"},{"key":"10.3233\/JAD-200488_ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-019-0740-x"},{"key":"10.3233\/JAD-200488_ref29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/nu11040819","article-title":"The preventive and curative effects of Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 on immobilization stress-induced anxiety\/depression and colitis in mice","volume":"11","author":"Jang","year":"2019","journal-title":"Nutrients"},{"key":"10.3233\/JAD-200488_ref30","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1007\/s12035-018-1283-6","article-title":"Brain-derived neurotrophic factor in brain disorders: Focus on neuroinflammation","volume":"56","author":"Lima Giacobbo","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-200488_ref31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/156720510790274473","article-title":"Alzheimer\u2019s disease (AD) and mild cognitive impairment (MCI) patients are characterized by increased BDNF serum levels","volume":"7","author":"Angelucci","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-200488_ref32","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1084\/jem.20182386","article-title":"Sex-specific effects of microbiome perturbations on cerebral Ab amyloidosis and microglia phenotypes","volume":"216","author":"Dodiya","year":"2019","journal-title":"J Exp Med"}],"updated-by":[{"DOI":"10.1177\/13872877251407772","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000}}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-200488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:37Z","timestamp":1777370917000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-200488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":31,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-200488","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}